MHRA Highlights Safety Risks After Botulinum Toxin Reports
The UK’s medicines regulator has highlighted safety concerns linked to botulinum toxin products following reports of suspected adverse effects. The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding healthcare professionals and consumers about the importance of using approved products and ensuring treatments are carried out by qualified practitioners. Botulinum toxin injections are widely used … Read more